CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin‐C vs surgical management in low‐risk non‐muscle‐invasive bladder cancer. (8th September 2020) - Montorsi, Francesco; Moschini, Marco; Necchi, Andrea